Meridian Bioscience Depreciation & Amortization 2011-2026 | VIVO

Annual Depreciation & Amortization Meridian Bioscience

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
16.5 M	15.3 M	13.6 M	9.96 M	8.69 M	9.09 M	7.72 M	6.61 M	7.26 M	7.15 M	6.6 M	5.87 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
16.5 M	5.87 M	9.53 M

Quarterly Depreciation & Amortization Meridian Bioscience

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
1.64 M	-	-	2.48 M	1.7 M	-	3.07 M	2.14 M	1.51 M	3.76 M	2.44 M	1.51 M	1.22 M	3.98 M	2.56 M	1.22 M	1.25 M	3.32 M	2.24 M	1.25 M	1.15 M	3.26 M	2.15 M	1.15 M	1.08 M	2.87 M	1.78 M	1.08 M	896 K	2.58 M	1.83 M	896 K	927 K	2.63 M	1.76 M	927 K	888 K	2.52 M	1.67 M	888 K	815 K	2.66 M	1.76 M	815 K	903 K	2.52 M	1.71 M	903 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
3.98 M	815 K	1.83 M

Depreciation & Amortization of other stocks in the Diagnostics research industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Akumin AKU	98.2 M	-	-17.87 %	$ 25.9 M	Canada
Burning Rock Biotech Limited BNR	47.8 M	$ 16.65	-	$ 179 M	China
Agilent Technologies A	321 M	$ 113.98	-0.78 %	$ 34.6 B	USA
Accelerate Diagnostics AXDX	1.7 M	-	-61.36 %	$ 2.46 M	USA
Aspira Women's Health AWH	112 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	1.66 M	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	2.55 M	-	0.22 %	$ 16.8 M	USA
Castle Biosciences CSTL	16 M	$ 24.15	-2.23 %	$ 671 M	USA
Check-Cap Ltd. CHEK	161 K	-	-	$ 9.42 M	Israel
Co-Diagnostics CODX	1.11 M	$ 1.61	-1.21 %	$ 2.14 M	USA
CareDx, Inc CDNA	15 M	$ 22.01	0.43 %	$ 1.17 B	USA
DermTech DMTK	200 K	-	-11.32 %	$ 2.94 M	USA
Enzo Biochem ENZ	1.27 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	125 M	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	24.9 M	$ 15.24	-0.39 %	$ 461 M	USA
Illumina ILMN	354 M	$ 125.07	-1.46 %	$ 19.9 B	USA
Global Cord Blood Corporation CO	43.3 M	-	-	$ 399 M	China
Charles River Laboratories International CRL	403 M	$ 167.08	0.22 %	$ 8.28 B	USA
HTG Molecular Diagnostics HTGM	587 K	-	-20.0 %	$ 1.06 M	USA
Guardant Health GH	39.7 M	$ 82.63	-0.59 %	$ 10.4 B	USA
Lantheus Holdings LNTH	70.1 M	$ 82.9	-0.78 %	$ 5.59 B	USA
Heska Corporation HSKA	14 M	-	-	$ 1.31 B	USA
Interpace Biosciences IDXG	425 K	$ 1.93	-	$ 8.54 M	USA
Personalis PSNL	10.9 M	$ 5.34	-2.92 %	$ 316 M	USA
Senseonics Holdings SENS	1.51 M	$ 7.03	-2.09 %	$ 293 M	USA
QIAGEN N.V. QGEN	194 M	-	-	$ 10.6 B	Niderland
Medpace Holdings MEDP	27.2 M	$ 403.62	-1.5 %	$ 11.6 B	USA
Biomerica BMRA	87 K	$ 2.18	-0.46 %	$ 5.01 M	USA
Motus GI Holdings MOTS	451 K	-	-34.28 %	$ 263 K	Israel
ICON Public Limited Company ICLR	488 M	$ 111.86	9.14 %	$ 9.23 B	Irlanda
Laboratory Corporation of America Holdings LH	681 M	$ 260.29	0.29 %	$ 21.7 B	USA
NeoGenomics NEO	36.1 M	$ 9.6	6.43 %	$ 1.23 B	USA
Twist Bioscience Corporation TWST	24.9 M	$ 57.42	-2.92 %	$ 3.43 B	USA
Celcuity CELC	167 K	$ 118.83	-1.04 %	$ 5.56 B	USA
Neogen Corporation NEOG	119 M	$ 9.19	-1.61 %	$ 1.99 B	USA
National Research Corporation NRC	7.62 M	$ 15.88	-5.7 %	$ 355 M	USA
Myriad Genetics MYGN	53.7 M	$ 4.77	-1.45 %	$ 442 M	USA
Natera NTRA	16.7 M	$ 196.02	-2.08 %	$ 19.3 B	USA
Quest Diagnostics Incorporated DGX	570 M	$ 192.19	-1.43 %	$ 21.3 B	USA
Invitae Corporation NVTA	142 M	-	-	$ 21.2 M	USA
Exagen XGN	2.1 M	$ 2.68	-1.83 %	$ 57.8 M	USA
OpGen OPGN	175 K	-	-16.95 %	$ 1.54 M	USA